Phathom Pharmaceuticals, Inc. SEC filings PHAT
Phathom Pharmaceuticals, Inc. has 495 filings in SEC EDGAR's recent list, going back to Jul 26, 2019. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Other events
|
Oct 26, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Other events
|
Oct 23, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Other events
|
Sep 29, 2026 | Sep 29, 2026 |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Other events
|
Jun 23, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 21, 2026 | May 19, 2026 |
| 10-Q | Quarterly report | Apr 30, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 30, 2026 | Apr 30, 2026 |
| DEFA14A | Additional proxy material | Apr 7, 2026 | — |
| ARS | Annual report to shareholders | Apr 7, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 7, 2026 | May 19, 2026 |
| S-8 | Employee stock plan registration | Mar 27, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Other events
|
Jan 8, 2026 | Jan 7, 2026 |
| 424B5 | Prospectus supplement | Jan 8, 2026 | — |
| 424B5 | Prospectus supplement | Jan 7, 2026 | — |
| 8-K |
Current report
Results of operations
|
Jan 7, 2026 | Jan 7, 2026 |
| S-3ASR | Automatic shelf registration | Jan 7, 2026 | — |
| 8-K |
Current report
Other events
|
Nov 4, 2025 | Nov 4, 2025 |
| 10-Q | Quarterly report | Oct 30, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2025 | Oct 30, 2025 |
| 8-K |
Current report
Other events
|
Oct 27, 2025 | Oct 25, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 6, 2025 | Oct 2, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Other events
|
Jun 16, 2025 | Jun 16, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 6, 2025 | Jun 6, 2025 |
| 10-Q | Quarterly report | May 1, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 1, 2025 | May 1, 2025 |
| ARS | Annual report to shareholders | Apr 23, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 23, 2025 | — |
| DEF 14A | Proxy statement | Apr 23, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 16, 2025 | Apr 11, 2025 |
| S-8 | Employee stock plan registration | Apr 3, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2025 | Mar 31, 2025 |
| S-8 | Employee stock plan registration | Mar 6, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 6, 2025 | Mar 6, 2025 |
| 10-K | Annual report | Mar 6, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Dec 11, 2024 | Dec 11, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Other events
|
Aug 19, 2024 | Aug 19, 2024 |
| 424B5 | Prospectus supplement | Aug 19, 2024 | — |
| FWP | Free writing prospectus | Aug 19, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Other events
|
Jul 18, 2024 | Jul 18, 2024 |
| UPLOAD | Letter from the SEC | Jun 25, 2024 | — |
| 10-K/A | Amended annual report | Jun 14, 2024 | Dec 31, 2023 |
| 10-Q/A | Amended quarterly report | Jun 14, 2024 | Mar 31, 2024 |
| CORRESP | Letter to the SEC | Jun 14, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2024 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
May 24, 2024 | May 23, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| DEFA14A | Additional proxy material | Apr 12, 2024 | — |
| DEF 14A | Proxy statement | Apr 12, 2024 | May 23, 2024 |
| ARS | Annual report to shareholders | Apr 12, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 7, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 7, 2024 | Mar 7, 2024 |
| 8-K |
Current report
Other events
|
Feb 13, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 15, 2023 | Dec 13, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 14, 2023 | Dec 14, 2023 |
| 8-K |
Current report
Other events
|
Dec 6, 2023 | Dec 6, 2023 |
| 8-K |
Current report
Other events
|
Nov 28, 2023 | Nov 28, 2023 |
| EFFECT | Filing | Nov 17, 2023 | — |
| CORRESP | Letter to the SEC | Nov 15, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2023 | — |
| S-3 | Shelf registration | Nov 9, 2023 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Other events
|
Nov 1, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Other events
|
Oct 30, 2023 | Oct 30, 2023 |
| 8-K |
Current report
Other events
|
Sep 26, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Other events
|
Aug 21, 2023 | Aug 21, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 17, 2023 | Jul 14, 2023 |
| SC TO-I/A | Filing | Jul 17, 2023 | — |
| SC TO-C | Filing | Jun 15, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 15, 2023 | Jun 15, 2023 |
| SC TO-I | Filing | Jun 15, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 12, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results, Other events
|
May 30, 2023 | May 25, 2023 |
| 8-K |
Current report
Other events
|
May 24, 2023 | May 23, 2023 |
| 424B5 | Prospectus supplement | May 24, 2023 | — |
| 424B5 | Prospectus supplement | May 23, 2023 | — |
| 8-K |
Current report
Other events
|
May 23, 2023 | May 23, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| DEFA14A | Additional proxy material | Apr 13, 2023 | — |
| DEF 14A | Proxy statement | Apr 13, 2023 | May 25, 2023 |
| ARS | Annual report to shareholders | Apr 13, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Other events
|
Apr 4, 2023 | Apr 4, 2023 |
| PRE 14A | Preliminary proxy statement | Mar 31, 2023 | May 25, 2023 |
| 10-K | Annual report | Feb 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Other events
|
Feb 9, 2023 | Feb 9, 2023 |
| 8-K |
Current report
Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Other events
|
Jan 3, 2023 | Jan 3, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 8, 2022 |
| 10-Q/A | Amended quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Nov 1, 2022 | Oct 31, 2022 |
| 8-K |
Current report
Other events
|
Oct 24, 2022 | Oct 24, 2022 |
| 8-K |
Current report
Material agreement
|
Sep 29, 2022 | Sep 27, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 26, 2022 | Sep 22, 2022 |
| 8-K |
Current report
Material agreement
|
Aug 4, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2022 | Aug 2, 2022 |
| 10-Q | Quarterly report | Aug 2, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Shareholder vote results, Other events
|
May 27, 2022 | May 25, 2022 |
| 8-K |
Current report
Other events
|
May 25, 2022 | May 25, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
May 4, 2022 | May 3, 2022 |
| 8-K |
Current report
Other events
|
May 4, 2022 | May 3, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Apr 26, 2022 | Apr 25, 2022 |
| DEFA14A | Additional proxy material | Apr 12, 2022 | — |
| DEF 14A | Proxy statement | Apr 12, 2022 | May 25, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 28, 2022 | Mar 22, 2022 |
| 8-K |
Current report
Other events
|
Mar 14, 2022 | Mar 14, 2022 |
| S-8 | Employee stock plan registration | Mar 10, 2022 | — |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2022 | Mar 1, 2022 |
| 8-K |
Current report
Other events
|
Feb 9, 2022 | Feb 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 25, 2022 | Jan 19, 2022 |
| 10-Q | Quarterly report | Nov 8, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2021 | Nov 8, 2021 |
| 424B5 | Prospectus supplement | Oct 26, 2021 | — |
| 8-K |
Current report
Results of operations, Other events
|
Oct 18, 2021 | Oct 18, 2021 |
| 8-K |
Current report
Other events
|
Sep 27, 2021 | Sep 27, 2021 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
|
Sep 20, 2021 | Sep 17, 2021 |
| 8-K |
Current report
Other events
|
Sep 8, 2021 | Sep 8, 2021 |
| 10-Q | Quarterly report | Aug 10, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2021 | Aug 10, 2021 |
| 8-K |
Current report
Other events
|
Aug 5, 2021 | Aug 4, 2021 |
| 8-K |
Current report
Material agreement
|
Jul 8, 2021 | Jul 2, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 4, 2021 | Jun 3, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 25, 2021 | May 20, 2021 |
| 10-Q | Quarterly report | May 11, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 11, 2021 | May 11, 2021 |
| 8-K |
Current report
Other events
|
Apr 29, 2021 | Apr 29, 2021 |
| DEFA14A | Additional proxy material | Apr 6, 2021 | — |
| DEF 14A | Proxy statement | Apr 6, 2021 | May 21, 2021 |
| 10-K | Annual report | Mar 30, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2021 | Mar 30, 2021 |
| SEC STAFF LETTER | Filing | Mar 23, 2021 | — |
| SEC STAFF LETTER | Filing | Feb 23, 2021 | — |
| 8-K |
Current report
Material agreement
|
Dec 31, 2020 | Dec 30, 2020 |
| 424B5 | Prospectus supplement | Dec 17, 2020 | — |
| 8-K |
Current report
Other events
|
Dec 17, 2020 | Dec 16, 2020 |
| 424B5 | Prospectus supplement | Dec 15, 2020 | — |
| 8-K |
Current report
Other events
|
Dec 14, 2020 | Dec 14, 2020 |
| 8-K |
Current report
Other events
|
Nov 30, 2020 | Nov 30, 2020 |
| EFFECT | Filing | Nov 17, 2020 | — |
| CORRESP | Letter to the SEC | Nov 13, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 13, 2020 | — |
| S-3 | Shelf registration | Nov 10, 2020 | — |
| 10-Q | Quarterly report | Nov 10, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2020 | Nov 10, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 25, 2020 | Sep 22, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2020 | Aug 6, 2020 |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Officer or director change
|
Jul 13, 2020 | Jul 13, 2020 |
| 8-K |
Current report
Other events
|
Jun 15, 2020 | Jun 15, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 26, 2020 | May 20, 2020 |
| 8-K |
Current report
Results of operations
|
May 12, 2020 | May 12, 2020 |
| 10-Q | Quarterly report | May 12, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Material agreement
|
May 5, 2020 | May 5, 2020 |
| DEFA14A | Additional proxy material | Apr 8, 2020 | — |
| DEF 14A | Proxy statement | Apr 8, 2020 | May 21, 2020 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Mar 19, 2020 | Mar 17, 2020 |
| 10-K | Annual report | Mar 19, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Material agreement, New debt, Officer or director change
|
Mar 17, 2020 | Mar 11, 2020 |
| 8-K |
Current report
Listing notice, Officer or director change, Other events
|
Dec 2, 2019 | Nov 30, 2019 |
| 10-Q | Quarterly report | Nov 25, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 25, 2019 | Nov 25, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 29, 2019 | Oct 29, 2019 |
| S-8 | Employee stock plan registration | Oct 28, 2019 | — |
| 424B4 | Prospectus | Oct 28, 2019 | — |
| EFFECT | Filing | Oct 24, 2019 | — |
| S-1MEF | Filing | Oct 24, 2019 | — |
| CERT | 8a cert | Oct 23, 2019 | — |
| CORRESP | Letter to the SEC | Oct 22, 2019 | — |
| CORRESP | Letter to the SEC | Oct 22, 2019 | — |
| 8-A12B | Filing | Oct 16, 2019 | — |
| S-1/A | Amended registration statement | Oct 15, 2019 | — |
| CORRESP | Letter to the SEC | Sep 30, 2019 | — |
| S-1 | Registration statement | Sep 30, 2019 | — |
| DRSLTR | Filing | Sep 18, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2019 | — |
| SEC STAFF LETTER | Filing | Sep 10, 2019 | — |
| DRSLTR | Filing | Aug 30, 2019 | — |
| DRS/A | Filing | Aug 30, 2019 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PHAT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Florham Park, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1783183
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.